stockrow
Friday 6 November 2026
Export CVRX’s income statement to Excel — free account
CVRx, Inc.
CVRX Healthcare Medical Devices
CVRx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $56.7 million, up 10.4% from fiscal 2024.
- Revenue
- −5.84%
- EPS
- −6.12%
- Free cash flow
- −9.91%
- Total debt
- +18.6%
Quarter to September 2026, against a year earlier
0.87
0.60
−40.82%
Follow CVRX
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 3 | 4 |
+8 more TTM periods Free account |
| (172.17%) | (133.44%) | (106.96%) | (96.59%) | ||
| (53.55%) | (49.06%) | (45.93%) | (44.76%) | ||
ROIC |
(224.98%) | (218.09%) | (204.26%) | (244.03%) | |
Return on Tangible Assets |
(71.54%) | (64.62%) | (58.89%) | (58.85%) | |
Average Days of Receivables |
58.01 | 56.08 | 56.25 | 68.71 | |
Free Cash Flow per Share |
(1.54) | (1.55) | (1.52) | (1.56) | |
Free Cash Flow |
(42.04) | (41.05) | (40.15) | (40.75) | |
Capital Expenditures |
(0.40) | (0.60) | (0.59) | (0.58) | |
| Other line items | |||||
Cash ROIC |
(32.04%) | (28.69%) | (25.11%) | (24.77%) | |
Accounts Receivable Turnover |
6.78 | 7.39 | 6.52 | 5.68 | |
Accounts Payable Turnover |
2.03 | 2.32 | 2.84 | 2.59 | |
Inventory Turnover |
0.63 | 0.65 | 0.68 | 0.68 | |
Average Days of Payables |
191.32 | 176.64 | 134.05 | 168.34 | |
Days of Inventory on Hand |
629.49 | 594.03 | 554.59 | 536.02 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
19.67% | 20.20% | 19.80% | 19.65% | |
Selling, General and Administrative Expense of Revenue |
149.13% | 146.20% | 151.00% | 156.17% | |
Share Based Compensation of Revenue |
20.30% | 20.04% | 19.49% | 19.51% | |
Interest Coverage |
(8.03) | (8.07) | (8.44) | (8.80) | |
Operating CF/Net income |
0.78 | 0.78 | 0.75 | 0.75 | |
Depreciation/Fixed assets |
0.57 | 0.53 | 0.48 | 0.44 | |
Capex/Depreciation |
(0.36) | (0.55) | (0.56) | (0.58) | |
Revenue per Share |
2.21 | 2.31 | 2.24 | 2.17 | |
Operating CF per Share |
(1.53) | (1.53) | (1.50) | (1.54) | |
Capex per Share |
(0.01) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026